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Nonpathogenic Bacteria Alleviating Atopic Dermatitis
Inflammation Induce IL-10-Producing Dendritic Cells
and Regulatory Tr1 Cells
Thomas Volz1, Yuliya Skabytska1, Emmanuella Guenova1, Ko-Ming Chen1, Julia-Stefanie Frick2,
Carsten J. Kirschning3, Susanne Kaesler1, Martin Ro¨cken1 and Tilo Biedermann1
The beneficial effects of nonpathogenic bacteria are increasingly being recognized. We reported in a placebo-
controlled study with atopic dermatitis (AD) patients that cutaneous exposure to lysates of nonpathogenic
bacteria alleviates skin inflammation. To now unravel underlying mechanisms, immune consequences of sensing
nonpathogenic bacterium Vitreoscilla filiformis lysate (Vf) were characterized analyzing (1) differentiation of
dendritic cells (DCs) and, consecutively, (2) effector functions of DCs and T helper (Th) cells in vitro and in a
murine model of AD in NC/Nga mice in vivo. Topical treatment with Vf significantly reduced AD-like
inflammation in NC/Nga mice. Importantly, cutaneous exposure to Vf in combination with the allergen FITC
significantly also reduced subsequent allergen-induced dermatitis indicating active immune modulation. Indeed,
innate sensing of Vf predominantly induced IL-10-producing DCs, which was dependent on Toll-like receptor
2 (TLR2) activation. Vf-induced IL-10þ DCs primed naive CD4þ T helper cells to become regulatory IFN-glow
IL-10high Tr1 (type 1 regulatory T) cells. These IL-10high Tr1 cells were also induced by Vf in vivo and strongly
suppressed T effector cells and inflammation. In conclusion, we show that innate sensing of nonpathogenic
bacteria by TLR2 induces tolerogenic DCs and regulatory Tr1 cells suppressing T effector cells and cutaneous
inflammation. These findings indicate a promising therapeutic strategy for inflammatory skin diseases like AD.
Journal of Investigative Dermatology (2014) 134, 96–104; doi:10.1038/jid.2013.291; published online 25 July 2013
INTRODUCTION
Atopic dermatitis (AD) is a chronic inflammatory skin disease
with increasing prevalence rates, affecting up to 10–20% of
the children in western countries (Bieber, 2008; Boguniewicz
and Leung, 2010). Although the detailed mechanisms under-
lying inflammation of AD skin are not fully understood, a
defect in skin barrier function as well as an immune
dysbalance play a crucial role, leading to T helper cell type 2
(Th2)–biased immune responses (Palmer et al., 2006; Bieber,
2008; Irvine et al., 2011). Increased hygiene standards, less
infectious diseases, and lowered family sizes are claimed to
lead to microbial deprivation during early years of life that
facilitate misdirected effector immune responses rather than
the induction of immune tolerance (‘‘hygiene hypothesis’’),
contributing to increase and development of allergies and
atopic diseases (Strachan, 1989; Bach, 2002; von Mutius and
Vercelli, 2010). Surface organs like the skin are constantly
colonized with bacteria in the absence of detectable
inflammation, but the mechanisms that inhibit inflammation
or even induce tolerance to the local microbiota are still
enigmatic (Grice et al., 2009). A reduced genetic diversity of
Gram-negative gammaproteobacteria in the environment of
atopic individuals was observed that profoundly influenced
the skin microbiota, leading to a decrease in Gram-negative
bacterium Acinetobacter and the anti-inflammatory cytokine
IL-10, demonstrating that resident microbes shape cutaneous
immune homoeostasis (Hanski et al., 2012). These data ideally
complement analyses in mouse models that first demonstrated
the potential of Gram-negative bacterium Acinetobacter to
prevent allergies (Debarry et al., 2007; Conrad et al., 2009). In
contrast to prevention of allergic sensitizations, most thera-
peutic strategies reporting the oral use of nonpathogenic or the
so-called ‘‘probiotic’’ bacteria failed to show significant effects
in the treatment of AD (Lee et al., 2008; Boyle et al., 2009).
Recently, we performed a proof-of-concept study in patients
demonstrating that immune recognition of the nonpathogenic
microbe Vitreoscilla filiformis is a promising strategy to treat
AD when directly applied onto patients’ skin and not orally
(Gueniche et al., 2008). Based on these clinical findings we
hypothesized that immune recognition of Gram-negative
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nonpathogenic bacterium V. filiformis exploits an important
mechanism of microbial immune sensing, finally alleviating
inflammation by induction of tolerance.
Pattern recognition receptors such as Toll-like receptors
(TLRs) play a key role in detecting ‘‘pathogen-associated
molecular patterns’’ (Takeuchi and Akira, 2010; Volz et al.,
2010; Volz et al., 2012). Especially within surface organs,
dendritic cells (DCs) are equipped with numerous pattern
recognition receptors and act as sentinels to sense micro-
bes, leading to DC maturation and cytokine production
(Reis e Sousa, 2004; Joffre et al., 2009). Activated DCs are
the most potent directors of immune phenotypes in T cells,
determining T-cell polarization to the different Th subtypes.
During this process of Th cell differentiation, DC cytokines are
most important possibly also shaping regulatory T cells
(Kapsenberg, 2003; Bettelli et al., 2008; Volz et al., 2012).
Intriguing studies demonstrated that these pathways are also
critical for induction of tolerance to the microbiota (Round
and Mazmanian, 2010; Geuking et al., 2011).
Given the positive results from our proof-of-concept study
in AD patients, we investigated the underlying mechanisms.
AD-prone NC/Nga mice with Th2-dominated cutaneous
hypersensitivity to FITC showed, similar to AD patients,
alleviated dermatitis when their skin was exposed to
V. filiformis signals. Importantly, this therapeutic effect was
even more pronounced when the skin was exposed to
V. filiformis signals previous to allergen challenge, indicating
effective immune modulation. Indeed, V. filiformis signals
induced high levels of IL-10 in DCs via TLR2. These DCs
orchestrated the induction of IL-10high, IFN-glow-producing Tr1
(type 1 regulatory T) cells. This regulation was also detected in
AD mice after cutaneous exposure to Vf with dominant IL-10
production by T cells from skin-draining lymph nodes and
consecutively reduced T-cell proliferation and proinflamma-
tory cytokine production.
Thus, immune recognition of the Gram-negative nonpatho-
genic bacterium V. filiformis by DCs induces IL-10-producing
DCs and regulatory Tr1 cells. This pathway may generally be
functional when discriminating between ‘‘pathogenic’’ and
‘‘nonpathogenic’’ bacteria and could be exploited to alleviate
cutaneous inflammation such as in AD.
RESULTS
Exposure to nonpathogenic bacteria attenuates cutaneous
inflammation in a murine model of AD
We recently reported effective treatment of AD lesions by
topical treatment of V. filiformis lysate (Vf) in a double-blind,
placebo-controlled clinical trial (Gueniche et al., 2008). Thus,
we first asked whether Vf solely suppressed cutaneous
inflammation in AD at the time and site of application. To
this end, mice of the NC/Nga strain that have been shown to
develop AD-like skin lesions and clinical features most closely
resembling human AD were investigated (Matsuda et al.,
1997). NC/Nga mice sensitized to the allergen FITC clearly
developed dermatitis lesions as measured by a strong increase
in ear thickness following allergen challenge (Figure 1a). All
appropriate controls without sensitization and subsequently
challenged with FITC with or without Vf exposure showed ear
swelling responses that were always o0.03 mm. Dermatitis
was reduced by 425% in mice that received topical treatment
of ear skin with Vf during FITC challenge, indicating direct
anti-inflammatory properties of Vf (Figure 1a). However, these
effects remained somewhat limited. Therefore, we next asked
whether exposure to Vf could also orchestrate immune
modulation or tolerance mediating long-term effects in addi-
tion. Therefore, one group of FITC-sensitized mice was
exposed to Vf in combination with FITC and the effects of
this exposure were determined 1 week later by challenge with
the allergen only. Compared with the FITC-sensitized control
group, mice previously exposed to Vf together with FITC
showed significantly reduced ear swelling after allergen
challenge alone (Po0.01), with almost 50% reduction at the
peak of skin inflammation (Figure 1b). Importantly, we
determined antigen-specific immunoglobulin levels in all
mice sensitized to FITC with or without exposure to Vf and
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Figure 1. Cutaneous exposure to Vitreoscilla filiformis (Vf) attenuates skin
inflammation. (a) FITC-sensitized NC/Nga mice showed ear swelling responses
peaking at 24 hours after challenge and declining thereafter. Cutaneous
exposure of mice to Vf exclusively during challenge significantly reduced ear
swelling at 24 and 48 hours. Not sensitized but FITC-challenged mice
(gray lines) did not display marked ear swelling responses irrespective of
exposure to Vf. Percentage of reduction of ear swelling of FITC-sensitized
Vf-exposed mice compared with FITC-challenged mice not receiving Vf is
shown at the right. (b) Cutaneous exposure of mice to FITC together with Vf
only previous to the final challenge significantly reduced ear swelling 24 and
48 hours after FITC challenge compared with the positive control group.
Reduction of ear swelling was up to 50% compared with mice not being
exposed to Vf, as depicted in the right panel. One out of two independent
experiments is shown, mean±SEM, n¼ 5 mice per group. NS, not significant.
*Po0.05 and **Po0.01.
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found elevated antigen-specific immunoglobulin levels when
compared with naive control mice. We detected no difference
in FITC-specific IgG1 and IgG2a levels when comparing Vf
exposed with unexposed mice and only a slight reduction in
antigen-specific IgE (Supplementary Figure S1 online). Thus,
Vf attenuated cutaneous T cell–mediated inflammation in a
murine model of AD by modes of immune modulation,
indicating that innate sensing of nonpathogenic V. filiformis
regulates even already established adaptive immunity.
Signals from nonpathogenic bacterium V. filiformis induce
maturation of human and murine DCs
Immune modulation or tolerance can be induced by immature
or semimature DCs not fully activated. To investigate DC
activation, murine bone marrow–derived dendritic cells
(BMDCs) and human monocyte-derived dendritic cells were
stimulated with either lipopolysaccharide (LPS) as positive
control or Vf for 24–48 hours. DC maturation was assessed by
FACS analysis.
Both Vf and LPS unequivocally induced maturation of
BMDCs as detected by upregulation of maturation markers
such as CD80, CD86, CD83, and major histocompatibility
complex class II as compared with untreated cells (Figure 2a).
After activation of human monocyte-derived dendritic cells
with Vf or LPS, CD83, the most reliable surface marker for
detection of human DC maturation, was also clearly upregu-
lated (Supplementary Figure S2a online). This shows that
signals of V. filiformis orchestrate the development of pheno-
typically mature DCs as determined by FACS analysis.
Signals from nonpathogenic bacterium V. filiformis orchestrate
the induction of IL-10high DCs
Next we analyzed cytokine production of DCs after activation
with either Vf or LPS. As expected, LPS induced high amounts
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Figure 2. Signals of Vitreoscilla filiformis (Vf) predominantly induce IL-10-producing mature dendritic cells (DCs). DCs were exposed to Vf or lipopolysaccharide
(LPS). (a) Vf and LPS unequivocally stimulated murine bone marrow–derived dendritic cells (BMDCs) to upregulate CD80, CD86, major histocompatibility
complex class II (MHC II), and CD83 (filled area) compared with untreated cells indicating full DC maturation. Gray lines indicate isotype controls. Unstim,
unstimulated. (b) BMDCs activated with Vf produced high levels of IL-10 but only low amounts of IL-12p70, characteristic for IL-10þ DCs. In contrast and, as
expected, LPS induced high IL-12p70 but only low IL-10 levels in BMDCs. Representative data from one out of four independent experiments are shown.
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of IL-12p70 and low levels of IL-10. In sharp contrast,
stimulation with Vf led to a DC cytokine profile dominated
by the anti-inflammatory cytokine IL-10, whereas IL-12p70
levels remained low for all V. filiformis strains investigated
(Figure 2b and Supplementary Figure S3 online). This IL-10
production induced by Vf was dose dependent in both human
and mouse DCs, indicating ligand(s) that trigger pattern
recognition receptors (Supplementary Figure S2b online).
Moreover, investigating numerous synthetic and bacterial-
derived TLR2 ligands, Vf was always superior in the induction
of IL-10 in DCs (Supplementary Figure S4 online). These data
demonstrate that innate immune sensing of nonpathogenic
bacteria governs DCs to predominantly produce the anti-
inflammatory and potentially tolerogenic cytokine IL-10.
Innate immune pathways for DC activation and IL-10 production
following encounter of signals from nonpathogenic bacterium
V. filiformis
To gain further insight into innate immune pathways activated
by Vf, we first investigated WT and MyD88 / DCs. DC
maturation was induced in WT DCs in response to TLR2
ligand Pam2Cys (data not shown), TLR4 ligand LPS, and Vf as
detected by upregulation of major histocompatibility complex
class II, CD80, CD83, and CD86 (Figure 3a). In contrast, but
as expected, Pam2Cys was unable to induce maturation of
MyD88 / DCs (data not shown) and DC maturation in
response to LPS was partially hampered. Strikingly, lack of
MyD88 did not affect DC maturation in response to Vf,
indicating that MyD88-independent pathways are at least in
part functional for DC maturation induced by nonpathogenic
bacteria (Figure 3a).
In sharp contrast to DC maturation, production of IL-10 and
IL-12p70 was almost completely abolished in MyD88 /
DCs (data not shown). Thus, DC maturation and cytokine
production operate via distinct innate immune pathways.
To investigate the pathways that lead to DC cytokine
production following contact to nonpathogenic bacteria, the
consequences of Vf exposure were investigated in BMDCs
lacking either TLR2 or TLR4. Strikingly, IL-10 production
was almost completely dependent on TLR2, as IL-10 was
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Figure 3. Distinct innate immune pathways control dendritic cell (DC) maturation and cytokine production induced by Vitreoscilla filiformis lysate (Vf).
(a) Exposure to Vf also induced DC maturation in DCs lacking Toll-like receptor (TLR) adaptor protein MyD88, whereas it partially reduced lipopolysaccharide (LPS)-
induced DC maturation. (b) Vf-induced IL-10 secretion was significantly reduced in TLR2 / but only marginally affected in TLR4 / DCs. In contrast, IL-12p70
production is almost completely abrogated in TLR4 / . (c) Sustained Vf-induced IL-10 production in wild-type (WT) or TLR4 / DCs following pretreatment with
LPS-scavenger Polymyxin B but reduced Vf-induced IL-12p70 production in WT and TLR2 / DCs. Representative data (mean±SD) from one out of three
independent experiments are shown. MHC II, major histocompatibility complex class II; NS, not significant; Unstim, unstimulated. **Po0.01 and ***Po0.001.
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significantly reduced in TLR2 / DCs (Figure 3b). This
indicates that ligand(s) of TLR2 within Vf is/are respon-
sible for induction of high IL-10 levels. In sharp contrast to
TLR2 / DCs, IL-10 production was only marginally reduced
in TLR4 / DCs (Figure 3b). The low IL-12p70 levels induced
by Vf were also further investigated. Lack of TLR2 significantly
increased IL-12p70 production, presumably because of the
diminished IL-10 levels, whereas the absence of TLR4 abro-
gated the induction of the proinflammatory cytokine IL-12p70.
Thus, we conclude that during DC exposure to Vf, at least two
different dominant pathogen associated molecular patterns are
functional: TLR2 ligand(s) inducing high IL-10 levels and TLR4
ligand(s) responsible for induction of IL-12p70. The latter is
presumably LPS.
To further characterize the nature of the different pathogen
associated molecular patterns inducing either IL-10 or
IL-12p70 WT, TLR2 / , and TLR4 / DCs were activated
in the presence or absence of Polymyxin B that neutralizes
LPS. Low IL-12p70 levels that were detected in WT and
TLR2 / DCs following exposure to Vf were nearly com-
pletely suppressed after preincubation of Vf with Polymyxin B,
demonstrating that V. filiformis LPS is responsible for IL-12p70
induction (Figure 3c). Importantly, Polymyxin B treatment
did not alter IL-10 production in WT, TLR2 / , and
TLR4 / DCs compared with DCs stimulated with Vf only
(Figure 3c). Thus, we conclude that innate immune signals
from nonpathogenic bacteria like V. filiformis activate TLR2
and induce high IL-10 levels independently from LPS and the
TLR4 pathway.
Priming of IL-10-producing CD4þ Tr1 cells by Vf-activated DCs
To assess the consequences on the adaptive immune system of
the innate immune sensing of Vf, cocultures of DCs with Th
cells were set up. First, DCs were activated with different
doses of Vf, pulsed with ovalbumin, and subsequently cocul-
tivated with naive CD4þ CD62Lþ OT-II Th cells. Increasing
concentrations of Vf in the previous DC culture reduced Th
cell proliferation as determined by [3H]-thymidine incorpora-
tion in a dose-dependent manner. This indicates direct
suppressive effects on Th cells mediated by DCs activated
with Vf (Figure 4a), which is in accordance to the observed
direct immunosuppressive effect in vivo (Figure 1a). To
determine immunomodulatory consequences on Th cell
polarization, DCs were activated with either LPS or Vf and
subsequently cocultivated for priming with Th cells as
described before. Primed Th cells were then expanded with
IL-2 for 10 days, stimulated, and analyzed for cytokine
production. Th cells primed by DCs that were activated with
LPS produced high IFN-g levels and no IL-4, indicating Th1
polarization (Figure 4b). In contrast, IFN-g levels secreted by
Th cells primed with Vf-exposed DCs were markedly reduced
compared with LPS-DCs and, again, IL-4 production was
undetectable (Figure 4b). Most importantly, Vf-exposed DCs
primed Th cells to secrete several fold higher levels of IL-10
compared with controls (Figure 4b). IL-10 production in T
cells was dependent on DC-derived IL-10 and TLR2 signaling
as both IL-10 / and TLR2 / DCs failed to induce high
IL-10 levels in T cells (Figure 4c). Thus, innate immune
sensing of Vf induced IL-10high, IFN-glow IL-4 Th cells
in an IL-10-dependent manner, indicating the induction of
Tr1 cells.
Regulatory function of Tr1 cells induced by Vf-exposed DCs
To assess the regulatory function of Tr1 cells primed by
Vf-exposed DCs, suppression assays with proliferating CD4þ
effector T cells were carried out. To this end, effector CD4þ
Th cells were labeled with carboxyfluorescein succinimidyl
ester (CFSE) and activated with anti-CD3/28 in the presence of
unlabeled Tr1 cells previously primed with Vf-exposed DCs.
To balance cell numbers, control experiments were performed
by adding unlabeled unpolarized CD4þ Th cells to CFSE-
labeled CD4þ effector Th cells. CFSE dilution was analyzed
72 hours after activation. Although addition of unpolarized Th
cells could not alter proliferation of CFSE-labeled effector Th
cells, Tr1 cells previously primed with Vf-exposed DCs
suppressed Th cell proliferation in a cell number–dependent
manner (Figure 4d and e).
Cutaneous exposure to signals of nonpathogenic bacterium
V. filiformis leads to enhanced T-cell IL-10 and inhibits T-cell
proliferation in vivo
To assess functional consequences of innate immune sensing
of nonpathogenic bacterium V. filiformis and consecutive
shaping of the adaptive immune system in vivo, NC/Nga mice
were again investigated. As described in Figure 1b, NC/Nga
mice were sensitized to FITC and were or were not exposed to
Vf. At 1 week after the last application, mice were challenged
at the ear skin with FITC alone. Whole lymph node cells from
the ear-draining lymph nodes isolated 8 hours after challenge
were restimulated with antigen (FITC) or anti-CD3/CD28
antibodies ex vivo. Only T cells from mice previously exposed
to Vf displayed antigen-specific production of IL-10, whereas
control mice failed to do so (Figure 5a). Using anti-CD3/CD28
antibodies, immune modulation and induction of IL-10 pro-
duction in T cells in vivo by previous exposure to V. filiformis
signals was confirmed (Figure 5b). Consistently, exposure to
V. filiformis signals reduced T-cell proliferation in draining
lymph nodes in vivo as measured by [3H]-thymidine uptake
ex vivo following FITC restimulation (Figure 5c). To analyze
the effect of enhanced IL-10 production on effector T-cell
responses in vivo, IFN-g, the hallmark cytokine of chronic AD,
was analyzed ex vivo (Grewe et al., 1995; Biedermann, 2006).
Consistent with the reduced T-cell proliferation, antigen-
specific IFN-g production by T cells was significantly
reduced in mice previously exposed to V. filiformis signals
(Figure 5d).
Together, these data show that signals of nonpathogenic
bacterium V. filiformis induce IL-10high T cells in vivo and
inhibit antigen-specific T-cell proliferation and cytokine pro-
duction, thus demonstrating the immunomodulatory role of
nonpathogenic innate immune signals in vivo.
DISCUSSION
Modulating immune responses at surface organs using non-
pathogenic bacteria is a promising strategy to treat inflamma-
tory diseases as reported in clinical trials on inflammatory
T Volz et al.
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bowel disease (Rembacken et al., 1999). We recently
demonstrated that nonpathogenic bacteria are also
functional when applied to the skin, alleviating cutaneous
inflammation in AD patients (Gueniche et al., 2008). To
analyze the underlying mechanism and to elucidate how
nonpathogenic bacteria may shape and modulate immune
responses, we investigated consequences of innate immune
sensing of V. filiformis in vitro and in vivo. NC/Nga mice
sensitized to FITC are characterized by a predominance of Th2
cells and high IgE levels and develop AD-like skin
inflammation as measured by increase of ear thickness after
FITC challenge (Matsuda et al., 1997; Dearman and Kimber,
2000; Matsuoka et al., 2003). Cutaneous treatment of these
NC/Nga mice with Vf during elicitation of skin inflammation
significantly decreased allergen-specific dermatitis, indicat-
ing direct immunosuppressive effects of Vf. Importantly,
cutaneous exposure to Vf and FITC antigen before the final
allergen challenge resulted in even more pronounced
suppression of cutaneous inflammation demonstrating
immunomodulatory properties of Vf. This indicates that
cutaneous treatment with Vf in AD patients is effective by
direct and immunomodulatory pathways (Gueniche et al.,
2008). Indeed, in vitro analyses demonstrated that signals of
V. filiformis induced a DC phenotype dominated by IL-10
already suggesting regulatory and tolerogenic properties
(Lutz and Schuler, 2002; Frick et al., 2010). In fact, DCs
activated by signals of V. filiformis effectively induced
regulatory T cells.
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It was known that IL-10 production by DCs contributes to
the induction of tolerance in various settings (Akbari et al.,
2001; Corinti et al., 2001; Yu et al., 2009). However, we
demonstrate according to our knowledge the previously
unreported finding that nonpathogenic Gram-negative
bacteria induce this tolerogenic DC phenotype characterized
by acquisition of a mature phenotype and a cytokine profile
dominated by the production of IL-10, and Tr1 induction. The
Gram-negative pathogen Bordetella pertussis has been shown
to exploit a similar strategy to subvert host immunity and
protective immune responses by induction of IL-10 and Tr1
cells (McGuirk et al., 2002). In accordance with previously
published results, we show that TLR adaptor molecule MyD88
is required for induction of both IL-10 and IL-12p70
production (Boonstra et al., 2006). Surprisingly, however,
DC maturation was independent of MyD88, indicating
activation of other innate immune pathways (Medzhitov,
2009; Takeuchi and Akira, 2010). The dependence of IL-10
production on TLR2 confirms and extends data from previous
reports demonstrating a dominant role for this pattern
recognition receptor in the induction of IL-10 in DCs (Dillon
et al., 2006; Depaolo et al., 2008). Lipoproteins have been
isolated and identified from Gram-negative E. coli initially and
lipopeptides derived thereof have been shown to activate
TLR2 (Braun and Wu, 1994; Buwitt-Beckmann et al., 2005).
TLR2 activation by bacterial or synthetic ligands can result in
either inflammatory or tolerogenic immune responses, but
detailed mechanisms are still to be deciphered (Oliveira-
Nascimento et al., 2012). Lipoproteins from Staphyloccocus
aureus binding to TLR2 have been shown to be crucial in
induction of inflammation and clearance of bacteria (Schmaler
et al., 2009). In contrast, host immunity is subverted by
Yersinia pestis inducing Tr1 cells triggered by TLR2/6
binding of LcrV subsequently inducing IL-10 production
(Depaolo et al., 2008). Porin B from Neisseria meningitidis
is also a TLR2 ligand inducing DC activation (Singleton et al.,
2005). As both V. filiformis and N. meningitidis are Gram-
negative bacteria belonging to the family of Neisseriaceae, it is
tempting to speculate that the TLR2-activating ligand of
V. filiformis is a bacterial porin with predominant anti-
inflammatory properties (Strohl, 2005). In contrast to Gram-
negative pathogenic bacteria such as Salmonella spp. eliciting
proinflammatory immune responses, innate immune sensing
of nonpathogenic Gram-negative bacteria like V. filiformis is
not dominated by TLR4 signaling over TLR2 signaling and
induction of inflammation, but is characterized by a more
dominant TLR2 signaling and the induction of tolerance. One
may speculate that the functional dominance of tolerogenic
signals may be a general principle of how nonpathogenic
bacteria and their hosts organize their coexistence in the
absence of inflammation. Previously, it has been shown
that the exposure to Gram-negative gammaproteobacterium
Acinetobacter prevents allergic disease in mouse models and
correlates with IL-10 production from healthy but not from AD
individuals (Debarry et al., 2007; Conrad et al., 2009; von
Mutius and Vercelli, 2010; Hanski et al., 2012). This already
demonstrates that contact to Gram-negative nonpathogenic
bacteria leads to active immune recognition resulting in
tolerogenic cytokine production (Hanski et al., 2012).
Strikingly, atopic individuals harbor significantly lower
amounts of Acinetobacter on the skin and show diminished
IL-10 production (Hanski et al., 2012). In light of these findings
and our data, the pathways utilized by nonpathogenic Gram-
negative bacteria to induce tolerance seem to be promising
targets for therapeutic strategies.
DCs have been shown to play a central role in transmitting
innate immune signals into various types of adaptive immune
responses (Kapsenberg, 2003; Joffre et al., 2009). ‘‘Tolerogenic
DCs’’ can prime Th cells to become regulatory T cells. Among
these, Tr1 cells are characterized by the production of low
amounts of IFN-g but high levels of IL-10 (Groux et al., 1997;
O’Garra and Vieira, 2004; Shevach, 2006). Moreover, it has
been reported that immune modulation by Tr1 cells reduces
antigen-specific IgE but not antigen-specific IgG1 and IgG2a
levels, which is similar to our findings following exposure to
Vf (Cottrez et al., 2000), but in contrast to, e.g., low-zone
tolerance that has been reported to tremendously reduce
specific immunoglobulin levels (Steinbrink et al., 1996).
We could demonstrate that DCs activated by signals of
nonpathogenic V. filiformis are potent inducers of Tr1 cells
producing these signature cytokines. Moreover, these Tr1 cells
strongly inhibited Th cell responses demonstrating function-
ality. This is in accordance with previously published results
demonstrating that Tr1 cells are equally potent to FoxP3pos
natural regulatory T cells in controlling effector T-cell
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Figure 5. Cutaneous exposure to signals of Vitreoscilla filiformis (Vf)
enhances T-cell IL-10 and inhibits T-cell proliferation in vivo. Induction of
antigen-specific IL-10 production in draining lymph nodes was only detected
in (a) mice previously exposed to Vf and (b) could be mapped to T helper (Th)
cells as detected following anti-CD3/CD28 activation. (c) Vf-mediated immune
modulation in previously Vf-exposed mice also reduced antigen-specific T-cell
proliferation and (d) IFN-g production as detected in lymph node cells 72 hours
after in vivo challenge.
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responses (Vieira et al., 2004). However, in contrast to
FoxP3pos natural regulatory T cells, Tr1 cells are inducible,
indicating a feasible therapeutic strategy.
Identifying nonpathogenic bacteria with tolerogenic poten-
tial, crucial active microbial components within these bac-
teria, and activation pathways mediating active tolerance—
such as TLR2 signaling—points to very promising therapeutic
strategies in the treatment of inflammatory and allergic
diseases, especially of the surface organs such as AD.
MATERIALS AND METHODS
FITC induced antigen-specific contact hypersensitivity
NC/Nga mice (5 mice per group) were sensitized by administration of
0.25% FITC solution (dissolved in 1:1 acetone/dibutyl phthalate) on
the shaved abdomen on days 0, 7, and 14. At 7 days after the last
sensitization, mice were challenged by application of 0.25% FITC
solution on both sides of the ears. To determine the direct immuno-
suppressive effects of Vf, one group of mice was treated with Vf (20%
v/v) on the ear skin during the allergen challenge period. Ear thickness
was measured with a micrometer (Oditest; Kroeplin, Germany) and
data are expressed as change in ear thickness as compared with that
before treatment. The immunomodulatory effects of Vf were investi-
gated by coadministration of Vf (20% v/v) on the abdominal skin at
days  1, 7, 14, and 21, and not during challenge. At 7 days after the
last FITC contact, all mice were challenged by application of 0.25%
FITC solution onto the ears in the absence of Vf. Draining lymph
nodes were collected either 8 or 72 hours after challenge and whole
lymph node cells were cultivated with FITC or anti-CD3/CD28
antibodies for another 3 days. Cell culture supernatants were
subjected to ELISA.
Generation and activation of human monocyte-derived DCs
DCs were generated from adherent peripheral blood mononuclear
cells as previously described (Guenova et al., 2008). To induce DC
maturation, day 6 immature DCs (CD11cþ CD14 HLA-DRþ
CD86þ CD83 ) were cultured for an additional 24 or 48 hours in
the presence of LPS R595 or Vf.
Generation and stimulation of murine BMDCs
Murine BMDCs were generated as described previously (Lutz et al.,
1999). At day 8, cells were collected, washed, and seeded in
1 106 ml per well in 24-well-plates. DCs were stimulated with
LPS (1mg ml 1) or Vf (5% v/v) for 24 hours unless otherwise specified.
DC/T-cell coculture
Immature BMDCs were activated in the presence of ovalbumin
(50mg ml 1) with LPS or Vf. Subsequently, DCs were washed
extensively and cultivated together with naive CD4þCD62Lþ OT-II
Th cells in a ratio of 1:5 for 3 days. CD4þ T cells were then
expanded using IL-2 (50 U ml 1) for another 12 days. Resting T cells
were washed and restimulated with plate-bound anti-CD3
(2mg ml 1) and anti-CD28 (5mg ml 1) in 96-well plates. Cell culture
supernatants were harvested after 72 hours and subjected to ELISA.
Proliferation assays
Naive OT-II CD4þCD62Lþ T cells (2 105) were activated
with ovalbumin-pulsed and Vf-stimulated DCs (4 104) in 96-well
flat-bottom plates in a total volume of 200ml. After 5 days 0.25mCi
[3H]-thymidine was added and cells were harvested after another
10 hours. Incorporated [3H]-thymidine was measured using a micro
beta counter (Perkin Elmer, Wiesbaden, Germany).
To asses suppressive capacity of Vf-induced IL-10þ Tr1 cells,
unprimed CD4þ Th cells were isolated using magnetic cell isola-
tion as described. These CD4þ cells were labeled with 1mM CFSE
(Molecular Probes, Eugene, OR) according to the manufacturer’s
protocol and 2 105 CFSEþ CD4þ T cells were activated with
plate-bound anti-CD3 (2mg ml 1) and soluble anti-CD28 (5mg ml 1)
in the presence of activated Vf-induced IL-10þ Tr1 cells at the
indicated cell ratios. Controls were set up using CFSEþ CD4þ cells
cultivated together with unlabeled Th cells to ensure balanced cell
numbers. Proliferation was determined 72 hours after activation.
All mice were maintained under specific pathogen free conditions
at the animal facilities of the University of Tu¨bingen according to
local and federal guidelines.
Additional methods concerning animals, reagents, antibodies,
bacterial lysates, Th cell isolation, and description of FACS analysis
can be found online.
Statistical analysis
All data are presented as means±SD or SEM (where indicated) of one
representative experiment. Experiments were repeated at least three
times if not indicated otherwise and revealed comparable results.
Statistical analysis was performed with Student’s t-tests (two tailed).
Values of Po0.05 were considered as statistically significant.
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